Prevalence, trends, and outcomes of metabolically healthy obesity or overweight in stroke hospitalizations of elderly patients: A 2016–2019 US population analysis
{"title":"Prevalence, trends, and outcomes of metabolically healthy obesity or overweight in stroke hospitalizations of elderly patients: A 2016–2019 US population analysis","authors":"Arankesh Mahadevan , Monitha Pinnamaneni , Preet Doshi , Muskan Kohli , Manaswini Krishnakumar , Rishabh Baskara Salian , Sai Anusha Akella , Santoshini Adivi , Akhila Reddy Radhareddy , Rupak Desai","doi":"10.1016/j.jns.2025.123445","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Obesity and overweight have been associated with an increase in the risk of stroke and poor outcomes. Meanwhile, Metabolically healthy obesity and overweight (MHOO) trends are understudied in association with stroke. This study aims to analyze the MHO trends and outcomes concerning stroke.</div></div><div><h3>Methods</h3><div>We queried the National Inpatient Sample (2016–2019) to identify stroke hospitalizations in the metabolically healthy (MH) elderly population (≥ 65 years) with vs. without obesity or overweight (OO) by using ICD-10 codes after excluding patients with hypertension, hyperlipidemia, and type 2 diabetes mellitus. Trends, demographics, comorbidities, and outcomes were then compared between the MHOO+vs and MHOO-ve cohorts.</div></div><div><h3>Results</h3><div>From 2016 to 2019, 7,242,846 hospitalizations were identified over age ≥ 65. Prevalence of stroke was higher in the MHOO-ve cohort (2.4 % vs 1.4 % <em>p</em> < 0.001). The MHOO-ve cohort was older (78 vs. 73 years), had a higher male presence (48.2 % vs. 36.4 %), Hispanics (5.1 % vs. 4.7 %), Whites (83.8 % vs. 82.3 %), and Asians (2.4 % vs. 1.1 %). The all-cause death rate (15.9 % vs. 14.4 %) and home health care (16.6 % vs 12.4 %) were also higher in the MHOO-ve cohort. Regression analysis adjusted for confounders showed no significant association between Stroke and OO in the cohorts.</div></div><div><h3>Conclusion</h3><div>After excluding major cardiovascular risk factors, obesity and overweight were not significant independent predictors of in-hospital mortality in metabolically healthy elderly stroke patients. Further research is needed to explore other factors influencing this relationship.</div></div>","PeriodicalId":17417,"journal":{"name":"Journal of the Neurological Sciences","volume":"472 ","pages":"Article 123445"},"PeriodicalIF":3.2000,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the Neurological Sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0022510X25000620","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/3/2 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Obesity and overweight have been associated with an increase in the risk of stroke and poor outcomes. Meanwhile, Metabolically healthy obesity and overweight (MHOO) trends are understudied in association with stroke. This study aims to analyze the MHO trends and outcomes concerning stroke.
Methods
We queried the National Inpatient Sample (2016–2019) to identify stroke hospitalizations in the metabolically healthy (MH) elderly population (≥ 65 years) with vs. without obesity or overweight (OO) by using ICD-10 codes after excluding patients with hypertension, hyperlipidemia, and type 2 diabetes mellitus. Trends, demographics, comorbidities, and outcomes were then compared between the MHOO+vs and MHOO-ve cohorts.
Results
From 2016 to 2019, 7,242,846 hospitalizations were identified over age ≥ 65. Prevalence of stroke was higher in the MHOO-ve cohort (2.4 % vs 1.4 % p < 0.001). The MHOO-ve cohort was older (78 vs. 73 years), had a higher male presence (48.2 % vs. 36.4 %), Hispanics (5.1 % vs. 4.7 %), Whites (83.8 % vs. 82.3 %), and Asians (2.4 % vs. 1.1 %). The all-cause death rate (15.9 % vs. 14.4 %) and home health care (16.6 % vs 12.4 %) were also higher in the MHOO-ve cohort. Regression analysis adjusted for confounders showed no significant association between Stroke and OO in the cohorts.
Conclusion
After excluding major cardiovascular risk factors, obesity and overweight were not significant independent predictors of in-hospital mortality in metabolically healthy elderly stroke patients. Further research is needed to explore other factors influencing this relationship.
肥胖和超重与中风和不良预后的风险增加有关。与此同时,代谢健康型肥胖和超重(MHOO)趋势与中风的关系尚未得到充分研究。本研究旨在分析脑卒中的MHO趋势和结果。方法对2016-2019年全国住院患者样本进行查询,在排除高血压、高脂血症和2型糖尿病患者后,使用ICD-10编码识别代谢健康(MH)老年人群(≥65岁)卒中住院与非肥胖或超重(OO)。然后比较MHOO+vs和MHOO-ve队列的趋势、人口统计学、合并症和结果。结果2016年至2019年,年龄≥65岁的住院病例为7242,846例。MHOO-ve组卒中患病率较高(2.4% vs 1.4% p <;0.001)。MHOO-ve队列年龄较大(78岁对73岁),男性患病率较高(48.2%对36.4%),西班牙裔(5.1%对4.7%),白人(83.8%对82.3%)和亚洲人(2.4%对1.1%)。全因死亡率(15.9%对14.4%)和家庭保健(16.6%对12.4%)在MHOO-ve队列中也较高。校正混杂因素的回归分析显示,在队列中卒中和OO之间没有显著的关联。结论在排除主要心血管危险因素后,肥胖和超重不是代谢健康老年脑卒中患者住院死亡率的显著独立预测因素。影响这一关系的其他因素还有待进一步研究。
期刊介绍:
The Journal of the Neurological Sciences provides a medium for the prompt publication of original articles in neurology and neuroscience from around the world. JNS places special emphasis on articles that: 1) provide guidance to clinicians around the world (Best Practices, Global Neurology); 2) report cutting-edge science related to neurology (Basic and Translational Sciences); 3) educate readers about relevant and practical clinical outcomes in neurology (Outcomes Research); and 4) summarize or editorialize the current state of the literature (Reviews, Commentaries, and Editorials).
JNS accepts most types of manuscripts for consideration including original research papers, short communications, reviews, book reviews, letters to the Editor, opinions and editorials. Topics considered will be from neurology-related fields that are of interest to practicing physicians around the world. Examples include neuromuscular diseases, demyelination, atrophies, dementia, neoplasms, infections, epilepsies, disturbances of consciousness, stroke and cerebral circulation, growth and development, plasticity and intermediary metabolism.